TheraRadar
Data updated: May 26, 2026

FLUOROMETHOLONE

Corticosteroid Hormone Receptor Agonists
Ophthalmology Approved 2024-01-09

FLUOROMETHOLONE is indicated for the treatment of Inflammation of the conjunctiva; Inflammation of the cornea.

Source: FDA Label • DIFGEN PHARMS
2
Indications
--
Phase 3 Trials
2
Years on Market

Details

Status
Prescription
First Approved
2024-01-09
Routes
OPHTHALMIC
Dosage Forms
SUSPENSION/DROPS

Companies

Active Ingredient: FLUOROMETHOLONE

FLUOROMETHOLONE Approval History

2025
2026
Original
New Indication
New Form
Label Update
2 FDA actions from 2024 to 2026
Feb 2026 ORIGINAL
Update
Jan 2024 ORIGINAL
Update

What FLUOROMETHOLONE Treats

2 indications

FLUOROMETHOLONE is approved for 2 conditions since its original approval in 2024. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Inflammation of the conjunctiva
  • Inflammation of the cornea
Source: FDA Label

FLUOROMETHOLONE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to FLUOROMETHOLONE

3 of 4

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

FLAREX
FLUOROMETHOLONE ACETATE
2 shared
HARROW EYE
Shared indications:
Inflammation of the ConjunctivaInflammation of the Cornea
OMNIPRED
PREDNISOLONE ACETATE
2 shared
Novartis
Shared indications:
Inflammation of the ConjunctivaInflammation of the Cornea
PRED FORTE
PREDNISOLONE ACETATE
2 shared
AbbVie
Shared indications:
Inflammation of the ConjunctivaInflammation of the Cornea
📋

Clinical Trial Registry

1 trials
Trial Sponsor ID Phase Status Title
NCT01448213 results posted 2011-0329 Ph 2 completed Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

FLUOROMETHOLONE FDA Label Details

Indications & Usage

FLUOROMETHOLONE is indicated for the treatment of Inflammation of the conjunctiva; Inflammation of the cornea.

Looking for the branded version?

FML FORTE

Full clinical data, patents, trials, and competitive landscape for fluorometholone.

See FML FORTE

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.